Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.

Cancer genetics and cytogenetics - 1 Dec 2010

Nana-Sinkam S Patrick, Croce Carlo M

Abstract excerpt

Chronic lymphocytic leukemia (CLL) is the most common form of leukemia among adults in the Western world, with an incidence of approximately 1 out of 100,000 patients per year. CLL is characterized by the clonal expansion of immature CD5(+) B cells. Although cytotoxic agents remain the mainstay of therapy, the disease of up to 20% of patients is not controlled with standard therapies. Therefore, there remains a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to 5' Untranslated Regions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Gene Expression Regulation, Leukemic

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Mice, Transgenic

Share to MicroRNAs

Share to Neoplasms

Source

Identifiers

PMID: 21156224
DOI: 10.1016/j.cancergencyto.2010.09.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.PMID 21156224Read ↗

Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.Semantic proximity Read ↗

Role of microRNAs in Chronic Lymphocytic Leukemia PathogenesisSemantic proximity Read ↗

Role of microRNAs in Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

microRNA and Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.Semantic proximity Read ↗

MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemiaSemantic proximity Read ↗

Role of microRNA in chronic lymphocytic leukemia onset and progressionSemantic proximity Read ↗

MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.Semantic proximity Read ↗

State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemiaSemantic proximity Read ↗

MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.Semantic proximity Read ↗

MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

The Role of MicroRNAs, CircRNAs, and LncRNAs in Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.